Marshall Wace’s Century Therapeutics IPSC Stock Holding History

Marshall Wace’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.52M	Buy	+673,584	New	+$1.42M	﹤0.01%	1932
2025 Q4	–	Sell	-54,161	Closed	-$27.1K	–	3192
2025 Q3	$27.1K	Sell	54,161 -85,546	-61%	-$46.1K	﹤0.01%	2770
2025 Q2	$78.2K	Buy	+139,707	New	+$75K	﹤0.01%	2566
2025 Q1	–	Sell	-35,511	Closed	-$35.9K	–	2849
2024 Q4	$35.9K	Buy	+35,511	New	+$48.3K	﹤0.01%	2498
2023 Q2	–	Sell	-110,316	Closed	-$383K	–	2699
2023 Q1	$383K	Buy	110,316 +52,818	+92%	+$232K	﹤0.01%	2212
2022 Q4	$295K	Sell	57,498 -643,840	-92%	-$6.08M	﹤0.01%	2575
2022 Q3	$6.94M	Hold	701,338	–	–	0.02%	1144
2022 Q2	$5.89M	Hold	701,338	–	–	0.01%	1226
2022 Q1	$8.83M	Hold	701,338	–	–	0.02%	963
2021 Q4	$11.1M	Buy	701,338 +589,786	+529%	+$11.1M	0.02%	793
2021 Q3	$2.81M	Buy	111,552 +58,803	+111%	+$1.59M	0.01%	1308
2021 Q2	$1.55M	Buy	+52,749	New	+$1.34M	0.01%	1585

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Marshall Wace's IPSC Position: Q1 2026 in Review

Marshall Wace opened a new position in Century Therapeutics (IPSC) in Q1 2026: 673,584 shares worth $1.52M. The stake represents ﹤0.01% of the portfolio and ranks #1932 among its holdings. This is a return to the name: Marshall Wace previously reported a position in IPSC as recently as Q3 2025.

Marshall Wace first reported a position in IPSC in Q2 2021 and has held it in 12 quarters since. The position peaked at $11.1M in Q4 2021. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

Marshall Wace held 673,584 shares of Century Therapeutics worth $1.52M as of Q1 2026.
Century Therapeutics was a new Marshall Wace position in Q1 2026.
Century Therapeutics made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1932 holding.
Marshall Wace first reported a position in Century Therapeutics in Q2 2021 and has held it in 12 quarters since.
Marshall Wace's Century Therapeutics position peaked at $11.1M in Q4 2021.
72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.